2Y4-21521-49096 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-21
Dose 1 — Pfizer-BioNTech
2021-04-03
Registered in v-safe
2021-04-03
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-04
Survey response — day 14, dose 1
MedDRA: Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activities

Free text: Sneezing and nonstop runny nose.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Report sent to call center — day 14, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-04-12
Dose 2 — Pfizer-BioNTech
2021-04-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-13
Survey response — days 1–6 daily, dose 2
MedDRA: No adverse event — Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: No

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-07-14
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-21	Pfizer-BioNTech
2	2021-04-12	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-04-04	priority 2/3

Free text

Release 6 — day 14, dose 1

2021-04-04

Symptoms: Sneezing and nonstop runny nose.

Release 7 — days 1–6 daily, dose 2

2021-04-13

Systemic reaction (other): No

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Rhinorrhoea	✓	✓	✓
SD	Sneezing	✓	✓	✓
SRO	No adverse event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release